SCHEDULE 14A
PROXY STATEMENT PURSUANT TO SECTION 14(A) OF THE SECURITIES EXCHANGE ACT OF 1934
(AMENDMENT NO. )
Filed by the Registrant [X]
Filed by a Party other than the Registrant [ ]
Check the appropriate box:
[ ] Preliminary Proxy Statement
[ ] Confidential, for Use of the Commission Only (as permitted by Rule 14a-6(e)(2))
[ ] Definitive Proxy Statement
[ ] Definitive Additional Materials
[X] Soliciting Material Pursuant to §240.14a-12
I-many, Inc.
(Name of Registrant as Specified In Its Charter)
(Name of Person(s) Filing Proxy Statement, if other than the Registrant)
Payment of Filing Fee (Check the appropriate box):
| [X] | No fee required. |
| [ ] | Fee computed on table below per Exchange Act Rules 14a-6(i)(1) and 0-11. |
| (1) | Title of each class of securities to which transaction applies: |
| (2) | Aggregate number of securities to which transaction applies: |
| (3) | Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state how it was determined): |
| (4) | Proposed maximum aggregate value of transaction: |
| (5) | Total fee paid: |
| [ ] | Fee paid previously with preliminary materials. |
| [ ] | Check box if any part of the fee is offset as provided by Exchange Act Rule 0-11(a)(2) and identify the filing for which the offsetting fee was paid previously. Identify the previous filing by registration statement number, or the Form or Schedule and the date of its filing. |
| (1) | Amount Previously Paid: |
| (2) | Form, Schedule or Registration Statement No.: |
| (3) | Filing Party: |
| (4) | Date Filed: |
Enterprise Contract Management Customers
Filed by I-many, Inc.
Pursuant to Rule 14a-12 of the Securities Exchange Act of 1934.
Subject Company: I-many, Inc.
Commission File No.: 000-30883
Frequently Asked Questions
Q. Why is I-many selling its Health & Life Sciences business?
A: The sale of the Health & Life Sciences business was a strategic decision to focus all of the company’s resources on developing the broadest and deepest enterprise contract management solution suite with the highest possible return on investment for our customers in the foodservice, consumer goods, high tech, manufacturing and service industries. The I-many enterprise contract management solutions suite includes the I-many collections, deductions, trade funds and CARS for Foodservice products.
Q: When is the deal expected to close?
A. The sale is expected to close near the end of Q3 2003, subject to approval by I-many’s shareholders and satisfaction of other customary closing conditions.
I-many & You
Q. What does the deal mean to me and how do I benefit?
A. I-many is passionately committed to developing enterprise contract management solutions that provide our customers with the highest possible return on investment. The sale of the I-many Health & Life Sciences business will enable I-many to put all of our capital resources and a fully dedicated team of world class technology, professional services and client services professionals behind this commitment.
Q. Will the I-many product release schedule or roadmap change?
A. Going forward, I-many will fuel its product roadmap and release schedule with a product research and development investment that is nearly twice the software industry average. This will enhance and accelerate development of our current products, including Contract Manager, Compliance Manager, Rebate Manager (CARS/RM), Collections Manager and Deductions Manager, as well as a number of new, benefit-rich enterprise contract management solutions.
Q. Will there be any senior management changes?
A. I-many does not anticipate senior management changes in its enterprise contract management business as a result of the sale.
Q. Will there be any professional service, client service or other support changes?
A. No, you can still expect to receive the same level of high quality service you have come to expect from I-many.
Q. What are I-many’s long-term plans?
A. I-many’s long-term plans have not changed. The Company is firmly committed to further expanding its leadership in the enterprise contract management solution space and adding even greater value for current and future customers.
Q. Who do I contact for additional information?
A. Please feel free to contact your I-many Account Executive with any questions or comments you may have. For your convenience, our toll-free telephone number is:800-832-0228. Alternatively, you can call Mark Smith, senior vice president and general manager, at (215) 794-3805.
